Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtalaya Mining Regulatory News (ATYM)

Share Price Information for Atalaya Mining (ATYM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 428.00
Bid: 425.00
Ask: 426.00
Change: 11.00 (2.64%)
Spread: 1.00 (0.235%)
Open: 417.50
High: 428.00
Low: 416.50
Prev. Close: 417.00
ATYM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US$14 million Prepayment Funding with Transamine

5 Sep 2016 07:00

RNS Number : 8925I
Atalaya Mining PLC
05 September 2016

Atalaya Mining plc ("Atalaya" or the "Company")

(AIM: ATYM, TSX: AYM)

US$14 million Prepayment Funding with Transamine Trading S.A.

The Company is pleased to announce the conclusion of a significant proportion of its funding requirements in relation to the mine expansion (the "Expansion Project"), through entering into a US$14 million copper concentrate prepayment agreement (the "Facility") with Transamine Trading S.A. ("Transamine").

Transamine, an independent and privately owned commodity trading company headquartered in Geneva, has been assigned part of the offtake agreements from existing offtakers.

Facility highlights

The duration of the Facility is from 1 January 2017 to 31 December 2018;

Under the terms of the Facility, Transamine will receive 60,000 Dry Metric Tonnes ("DMTs") per annum of copper concentrate;

The Company's subsidiary, EMED Marketing Limited ("EMED Marketing"), will have the ability to draw down the US$14 million prepayment funding following the signing of the agreement;

Terms and conditions of the Facility are based on standard market conditions. The Facility will bear interest at US$ 6 months LIBOR + 2.75%;

The Facility will be settled through agreed deductions from the payments received for each shipment;

Transamine has agreed to pay for copper concentrates at a price based on the prevailing metal prices for the copper and silver content around the time of shipment, less any applicable deductions, all pursuant to the terms of the prevailing offtake agreements;

EMED Marketing has the option to extend the contract, with the same terms, for an additional US$ 14 million provided certain production conditions have been met and the first US$ 14 million have been settled.

EMED Marketing's obligations to Transamine under the Facility are secured by ore and concentrates in stock and to be produced by the Company, in addition to new equipment purchased by the Company for the Expansion Project.

Alberto Lavandeira, CEO, commented:

"We are pleased to announce this commercial partnership with Transamine. The successful completion of this transaction, at competitive terms, represents a significant achievement for the Company. The funding proceeds will be used to cover part of the short term working capital requirements to support the Company through the ramp-up phase.

Ramp-up of production is progressing as planned, with the plant now running at 8.3 Mtpa annualized capacity and having produced 3,175 tonnes of copper during August. This is approximately a 30% improvement over July`s production of 2,442 tonnes of copper. Accumulated production for July and August 2016 is already 26% higher than the production of the second quarter of 2016, and is an indication of the good progress of the ramp-up of the Expansion Project that is expected to be working at full capacity by the end of 2016.

The Company will continue to work on alternative funding solutions to improve its balance sheet and its working capital position during the ramp-up period to full expanded production."

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

Contacts:

Atalaya Mining plc

Roger Davey / Alberto Lavandeira

+34 959 59 28 50

Canaccord Genuity (NOMAD and Joint Broker)

Henry Fitzgerald-O'Connor / Martin Davison

+44 20 7523 8000

BMO Capital Markets (Joint Broker)

Jeffrey Couch/Neil Haycock/Tom Rider

+44 20 7236 1010

This information is provided by RNS
The company news service from the London Stock Exchange
END
AGRDXGDCCUGBGLS
Date   Source Headline
11th Apr 20247:00 amRNSQ1 2024 Operations Update
19th Mar 20247:00 amRNS2023 Annual Results
8th Mar 20247:00 amRNSNotice of 2023 Annual Results
9th Feb 20247:00 amRNSIssue of Equity
18th Jan 20247:00 amRNSQ4 Operations Update and 2024 Production Guidance
21st Dec 20237:01 amRNSUpdate on Move to Main Market
21st Dec 20237:00 amRNSHolding(s) in Company
21st Dec 20237:00 amRNSHolding(s) in Company
20th Dec 20237:00 amRNSHolding(s) in Company
14th Dec 20231:49 pmRNSExtension of Port Handling Agreement
12th Dec 202311:28 amRNSResults of the 2023 Extraordinary General Meeting
12th Dec 20237:00 amRNS2023 Extraordinary General Meeting Statement
1st Dec 20237:00 amRNSHistorical Related Party Transactions
20th Nov 20237:00 amRNSHolding(s) in Company
16th Nov 20237:00 amRNSQ3 and YTD 2023 Financial Results
14th Nov 20237:00 amRNSProposed Re-domiciliation and Notice of EGM
13th Nov 20237:00 amRNSIntention to Move from AIM to Main Market
2nd Nov 20237:00 amRNSNotice of Q3 and YTD 2023 Financial Results
12th Oct 20237:00 amRNSQ3 2023 Operations Update
10th Oct 20233:11 pmRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSInterim Dividend Foreign Exchange Rates
10th Aug 20237:00 amRNSQ2 and H1 2023 Financial Results
27th Jul 20237:00 amRNSNotice of Q2 and H1 2023 Financial Results
20th Jul 20237:00 amRNSFinal Dividend Foreign Exchange Rates & Payment
20th Jul 20237:00 amRNSCorrection to Q2 Provisional Revenue Adjustments
12th Jul 20237:00 amRNSQ2 2023 Operations Update
10th Jul 20237:00 amRNSPDMR Shareholding
29th Jun 20237:00 amRNS2022 Final Dividend Timetable
28th Jun 202311:25 amRNSResults of the 2023 Annual General Meeting
28th Jun 20237:00 amRNS2023 Annual General Meeting Statement
26th Jun 20237:00 amRNSReport on Payments to Governments
26th Jun 20237:00 amRNSApproval to Cease to be Reporting in Canada
1st Jun 20237:00 amRNSNotice of AGM
30th May 20237:00 amRNSApplication to Cease to be a Reporting Issuer
23rd May 20237:00 amRNSGrant of Share Options and PDMR Notification
16th May 20237:00 amRNSPublication of 2022 Sustainability Report
15th May 20237:00 amRNSQ1 2023 Financial Results
2nd May 20237:00 amRNSNotice of Q1 2023 Results
17th Apr 20237:00 amRNSQ1 2023 Operations Update
28th Mar 20237:00 amRNSEnvironmental Authorisation Granted to PMV
24th Mar 20237:00 amRNSFiling of New Riotinto PEA Technical Report
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
22nd Mar 20237:00 amRNS2022 Annual Results
15th Mar 20237:00 amRNSNotice of 2022 Annual Results
13th Mar 20237:00 amRNSUpdate on Voluntary Delisting From The TSX
23rd Feb 20237:00 amRNSResults of New PEA for Riotinto
20th Feb 20237:00 amRNSVoluntary Delisting from the TSX
17th Jan 20237:00 amRNSQ4 Operations Update and 2023 Production Guidance
12th Jan 20237:00 amRNSHolding(s) in Company
24th Nov 20227:00 amRNSUpdate on Exploration Activities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.